Evidence map›Paper›PMID 38464112›Full record

ArticlebioRxiv : the preprint server for biology2024

PTM-Mamba: A PTM-Aware Protein Language Model with Bidirectional Gated Mamba Blocks.

Zhangzhi Peng, Benjamin Schussheim, Pranam Chatterjee

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 24 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Zhangzhi PengDepartment of Biomedical Engineering, Duke University.
Benjamin SchussheimDepartment of Computer Science, Duke University.
Pranam ChatterjeeDepartment of Biomedical Engineering, Duke University.ORCID 0000-0003-3957-8478
Duke University · US

Funding

Towards the Design of Programmable, Isoform-Selective Proteome Editing SystemR35GM155282 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Pranam Chatterjee · 2024 to 2026
$1.2M
Programmable peptide-guided protein degradationR21CA278468 · NCI · DUKE UNIVERSITY · PI CHATTERJEE, PRANAM · 2023 to 2023
$388k
NCI NIH HHS R21 CA278468NIGMS NIH HHS R35 GM155282
6 · The paper itself

Abstract

Proteins serve as the workhorses of living organisms, orchestrating a wide array of vital functions. Post-translational modifications (PTMs) of their amino acids greatly influence the structural and functional diversity of different protein types and uphold proteostasis, allowing cells to swiftly respond to environmental changes and intricately regulate complex biological processes. To this point, efforts to model the complex features of proteins have involved the training of large and expressive protein language models (pLMs) such as ESM-2 and ProtT5, which accurately encode structural, functional, and physicochemical properties of input protein sequences. However, the over 200 million sequences that these pLMs were trained on merely scratch the surface of proteomic diversity, as they neither input nor account for the effects of PTMs. In this work, we fill this major gap in protein sequence modeling by introducing PTM tokens into the pLM training regime. We then leverage recent advancements in structured state space models (SSMs), specifically Mamba, which utilizes efficient hardware-aware primitives to overcome the quadratic time complexities of Transformers. After adding a comprehensive set of PTM tokens to the model vocabulary, we train bidirectional Mamba blocks whose outputs are fused with state-of-the-art ESM-2 embeddings via a novel gating mechanism. We demonstrate that our resultant PTM-aware pLM,

Identifiers

PMID38464112
PMCPMC10925343
OpenAlexW4392352687

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.